Page 112 - IMO-1-1

Innovative Medicines & Omics SARS-CoV-2 inhibition by quinolines

Evol. 2023;15(4):evad035. Mechanism of action, clinical, and translational science.
Clin Transl Sci. 2024;17(2):e13732.
doi: 10.1093/gbe/evad035
66. Chen Y, Yang WH, Chen HF, et al. Tafenoquine and its doi: 10.1111/cts.13732
derivatives as inhibitors for the severe acute respiratory 72. Kabinger F, Stiller C, Schmitzová J, et al. Mechanism of
syndrome coronavirus 2. J Biol Chem. 2022;298(3):101658. molnupiravir-induced SARS-CoV-2 mutagenesis. Nat
doi: 10.1016/j.jbc.2022.101658 Struct Mol Biol. 2021;28(9):740-746.
67. Sacramento CQ, Fintelman-Rodrigues N, Temerozo JR, et al. doi: 10.1038/s41594-021-00651-0
In vitro antiviral activity of the anti-HCV drugs daclatasvir 73. Tan D, Walmsley S. Lopinavir plus ritonavir: A novel
and sofosbuvir against SARS-CoV-2, the aetiological agent of protease inhibitor combination for HIV infections. Expert
COVID-19. J Antimicrob Chemother. 2021;76(7):1874-1885. Rev Anti Infect Ther. 2007;5(1):13-28.
doi: 10.1093/jac/dkab072 doi: 10.1586/14787210.5.1.13
68. Li P, Wang Y, Lavrijsen M, et al. SARS-CoV-2 Omicron 74. De Wilde AH, Jochmans D, Posthuma CC, et al. Screening
variant is highly sensitive to molnupiravir, nirmatrelvir, and of an FDA-approved compound library identifies four small-
the combination. Cell Res. 2022;32(3):322-324. molecule inhibitors of middle east respiratory syndrome
doi: 10.1038/s41422-022-00618-w coronavirus replication in cell culture. Antimicrob Agents
Chemother. 2014;58(8):4875-4884.
69. Ruiz-Moreno AJ, Cedillo-González R, Cordova-Bahena L,
et al. Consensus pharmacophore strategy for identifying doi: 10.1128/AAC.03011-14
novel SARS-Cov-2 M inhibitors from large chemical 75. Chu CM, Cheng VC, Hung IF, et al. Role of lopinavir/
pro
libraries. J Chem Inf Model. 2024;64(6):1984-1995. ritonavir in the treatment of SARS: Initial virological and
doi: 10.1021/acs.jcim.3c01439 clinical findings. Thorax. 2004;59(3):252-256.
70. Wong W, Bai XC, Sleebs BE, et al. Mefloquine targets the doi: 10.1136/thorax.2003.012658
Plasmodium falciparum 80S ribosome to inhibit protein 76. Phosrithong N, Ungwitayatorn J. Molecular docking study
synthesis. Nat Microbiol. 2017;2(6):17031.
on anticancer activity of plant-derived natural products.
doi: 10.1038/nmicrobiol.2017.31 Med Chem Res. 2010;19(8):817-835.
71. Maas BM, Strizki J, Miller RR, et al. Molnupiravir: doi: 10.1007/s00044-009-9233-5

Volume 1 Issue 1 (2024) 106 doi: 10.36922/imo.3442